leisure time -WSS

leisure time

author：comprehensive 2025-09-29 01:29:29 - browse：4

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： What PEPFAR has meant on the ground in Ukraine

WSS

AI models in health care face new federal disclosure requirements

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

SCOTUS to consider access to abortion pill mifepristone

Obamacare plans could cover weight loss drugs

Radiology is caught between AI's potential and concern for patients

Opioid cravings were reduced by anti

leisure time

leisure time

focus

In age of alternative facts, a scholarly course on calling out crap

Obamacare plans could cover weight loss drugs

How one medical school became remarkably diverse

Researchers tackle phage therapy hurdles for wider adoption

Cancer drug shortages should be causing more outrage

FDA needs staff influx to meet gene therapy needs, Marks says

Continuity nursing helped my family in our darkest PICU moments

Medicare Advantage enrollment grows 7.1% to 33.4 million people

The high cost of giving birth even with insurance

Leukemia patients are helped by Syndax's new type of therapy

hotspot

A new drug could help frostbite victims avoid its ravages

Surprise medical billing ban raises prices elsewhere

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

MD Anderson's Padmanee Sharma responds to research credit suit

Secretariat’s lessons for human medicine

Roche to buy Carmot Therapeutics, developer of obesity drugs

knowledge

hotspot

leisure time

knowledge